We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


BioLife and Corning Announce Increased Cell Performance Through Product Combination

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "BioLife and Corning Announce Increased Cell Performance Through Product Combination"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

BioLife Solutions Inc. and Corning Incorporated have announced the publication of a report that describes the benefits of the combination of the BioLife CryoStor™ CS5 with Corning’s CellBIND® Surface. 

The integration of these complementary technologies resulted in a significant increase in the survival and attachment of LNCaP cells as compared to traditional solutions and tissue culture treated (TCT) surfaces. 

"This validation of serum-free and protein-free CryoStor provides an important endorsement of our preservation technology platform and intellectual property portfolio," said Mike Rice, chief executive officer, BioLife Solutions. 

"The study jointly performed by Corning and BioLife scientists demonstrates fundamental advantages that the combined products offer to a broad industry base, including drug discovery and cellular therapy."

Data from independent experiments showed that the Cryostor solution and Corning CellBIND surface product combination offered a 58-percent increase in post-preservation cell survival when compared to traditional tissue culture surface and serum and protein based freezing media.  

"It’s important to note that cell survival was measured 24 hours post-thaw, a much more relevant performance metric than immediate post-thaw survival measurement, which often gives researchers a false sense of practical cell function and viability," added John G. Baust, PhD,  chief scientific officer, BioLife Solutions.

"These independently verified results confirm the benefits of using the Corning CellBIND  surface combined with the protein-free BioLife CryoStorCS5 freezing solution to improve the survival of LNCaP cells," said Mark Beck, vice president and general manager, Corning Life Sciences. 

"Our relationship with BioLife further demonstrates our commitment to developing innovative technologies and/or partnering with industry leaders to provide our global customers with the solutions and expertise they require to improve performance and results."

The report, titled "Enhanced Survival of LNCaP Cells Following Cryopreservation Using the CryoStor CS5 Preservation Solutions and Corning CellBIND Surface," was co-authored by Corning and BioLife Solutions scientists and appeared in the Oct. 15, 2006 issue of Genetic Engineering News.